Related Experiment Video
Updated: May 16, 2025
06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.3K
On the achievability of efficiency bounds for covariate-adjusted response-adaptive randomization
Jiahui Xin1, Wei Ma1
1Institute of Statistics and Big Data, Renmin University of China, Beijing, China.
Statistical Methods in Medical Research
|April 1, 2025
Summary
Covariate-adjusted response-adaptive (CARA) randomization ethically tailors treatments. This study proves CARA designs can achieve the theoretical efficiency bound for discrete covariates, optimizing clinical trial efficiency.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Precision Medicine
Background:
- Covariate-adjusted response-adaptive (CARA) randomization is crucial for ethical and efficient clinical trials in precision medicine.
- Existing research focuses on robust inference and efficiency bounds in adaptive designs.
- Armstrong (2022) established the asymptotic efficiency bound for covariate-dependent randomization, but its achievability under CARA remained unaddressed.
Purpose of the Study:
- To determine if the asymptotic efficiency bound can be achieved under CARA randomization.
- To connect robust inference and efficiency bound literature for adaptive designs.
- To provide a definitive answer for CARA with discrete covariates.
Main Methods:
- Investigated a stratified version of the doubly-adaptive biased coin design, a type of CARA.
- Employed theoretical analysis to prove the achievability of the efficiency bound.
- Considered ethical constraints on treatment assignments.
Main Results:
- Demonstrated that the stratified difference-in-means estimator achieves Armstrong (2022)'s efficiency bound for CARA with discrete covariates.
- Established a link between robust inference and efficiency bounds in adaptive randomization.
- Addressed a key question regarding the practical implementation of CARA designs.
Conclusions:
- The study confirms that CARA designs can achieve the theoretical efficiency bound in practical scenarios with discrete covariates.
- This research offers new insights into optimizing CARA designs for maximum efficiency and ethical considerations.
- Future research should explore achieving the efficiency bound for CARA with continuous covariates.
Related Concept Videos
01:13Randomized Experiments
6.6K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.6K
01:25Strategies for Assessing and Addressing Confounding
72
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
72
01:20Comparing the Survival Analysis of Two or More Groups
96
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
96
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
01:15Assumptions of Survival Analysis
73
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
73
01:21Friedman Two-way Analysis of Variance by Ranks
112
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
112